Ishita Drugs and Industries informs about outcome of board meeting

14 Nov 2022 Evaluate

Pursuant to the regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Ishita Drugs and Industries has informed that the Board of Directors of the company, at its meeting held today 14th November, 2022 have: Approved the Unaudited Financial Results of the Company for the quarter ended 30th September, 2022. The company has enclosed Limited Review Report of the Unaudited Financial Results of the Company for the quarter ended 30th September, 2022 issued by the Statutory Auditors of the Company.

The above information is a part of company’s filings submitted to BSE.

Ishita Drugs & Inds. Share Price

78.24 2.31 (3.04%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.